Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs

Tingting Lin(Sanming University), Shuiliang Wang(Xiamen University)

Journal of Experimental & Clinical Cancer Research

April 8, 2019

10.1186/s13046-019-1160-9

Cited by 40

Related Papers

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer

|Breast Cancer Research|2013|56

MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer

|Oncotarget|2016|27

<p>Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT</p>

|Cancer Management and Research|2019|18